Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Potent NK1 antagonism by SR-140333 reduces rat colonic secretory response to immunocyte activation
Ist Teil von
American Journal of Physiology: Cell Physiology, 2001-04, Vol.280 (4), p.C852-C858
Ort / Verlag
United States
Erscheinungsjahr
2001
Quelle
Free E-Journal (出版社公開部分のみ)
Beschreibungen/Notizen
1 Department of Veterinary Physiology and Biochemistry and
3 Conway Institute of Biomolecular and Biomedical Research,
University College Dublin, Belfield, Dublin 4, Ireland; and
2 Department of Internal Medicine, Sanofi-Synthélabo,
92504 Rueil-Malmaison, France
The potent
neurokinin receptor 1 (NK 1 ) antagonist SR-140333
has previously been shown to reduce castor oil-induced secretion in
animal models. The importance of tachykinins in neuroimmune control of
secretion and the effect of SR-140333 on key points in this pathway
were elucidated in the present study to determine the type of
intestinal dysfunction best targeted by this antagonist. Rat colonic
secretion and substance P (SP) release were determined in vitro with
the use of Ussing chamber and enzyme immunoassay techniques.
NK 1 receptors played a secretory role as receptor agonists
stimulated secretion and SR-140333 antagonized the response to SP
response (pK b = 9.2). Sensory fiber stimulation
released SP and evoked a large secretion that was reduced by 69% in
the presence of SR-140333 (10 nM). Likewise, mastocytes also released SP. The subsequent secretory response was reduced by 43% in the presence of SR-140333 (50 nM). SP was also released from granulocytes; however, this did not cause secretion. Functional NK 3
receptors were present in the colon as senktide stimulated secretion,
an effect that was increased during stress. We conclude that
NK 3 receptors may play a role in stress-related disorders,
whereas NK 1 receptors are more important in mast
cell/afferent-mediated secretion.
afferent; granulocyte; irritable bowel syndrome; inflammatory bowel
disease; mast cell